The Patent Finder

Terms ending in 2029

Hoffmann-La Roche Inc.

Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,812,161Synthesis of GLYT-1 Inhibitors
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 7,972,846CADHERIN-11 Antagonists and Methods for the Treatment of Inflammatory Joint Disorders
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 9,315,568CADHERIN-11 EC1 Domain Antagonists for Treating Inflammatory Joint Disorders
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 10,927,163Bivalent, Bispecific Antibodies
In force
 · Medium confidence
Hoffmann-La Roche, Inc.In forceMedium confidence
US 8,846,762Benzopyran and Benzoxepin PI3K Inhibitor Compounds and Methods of Use
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 9,309,265Benzopyran and Benzoxepin PI3K Inhibitor Compounds and Methods of Use
In force
 · Low confidence
Hoffmann-La Roche Inc.In forceLow confidence
US 7,928,248Benzopyran and Benzoxepin PI3K Inhibitor Compounds and Methods of Use
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 7,846,336Chromatographic Methods
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 7,858,823Process for Cyclohexanecarboxylic Acid Derivatives
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 8,143,442Preparation for a Cyclohexanecarboxylic Acid Derivative and Intermediates
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
14 more term ends in 2029 · Pro
10 of 24 patents shown. Soonest term end first, then patent number.
Pro members see all 24.
Upgrade to Pro
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited